Q3 2020 Eagle Pharmaceuticals Inc Earnings Call Transcript
Good morning, everyone. My name is Reid, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Third Quarter 2020 Earnings Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded today, November 2, 2020.
It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead.
Thank you, Reid. Welcome to Eagle Pharmaceuticals Third Quarter Earnings Call. This is Lisa Wilson, Investor Relations for Eagle Pharmaceuticals.
With me on today's call are Eagle's Chief Executive Officer, Scott Tarriff; David Pernock, President and Chief Operating Officer; and our newly appointed Chief Financial Officer, Brian Cahill.
This morning, the company issued a press release detailing financial results for the 3 months ended September 30, 2020. This press release and a webcast of this call can be accessed through the Investors section of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |